Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2025-07-09 | 2025-07-09 |
| Drug Identification Number | 00428833 | 00428833 |
| Brand name | YF-VAX | YF-VAX |
| Common or Proper name | Yellow Fever Vaccine | Yellow Fever Vaccine |
| Company Name | SANOFI PASTEUR LIMITED | SANOFI PASTEUR LIMITED |
| Ingredients | YELLOW FEVER VACCINE | YELLOW FEVER VACCINE |
| Strength(s) | 109648PFU | 109648PFU |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 5 x 0.5 mL dose vials with diluent | 5 x 0.5 mL dose vials with diluent |
| ATC code | J07BL | J07BL |
| ATC description | VIRAL VACCINES | VIRAL VACCINES |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2025-07-04 | 2025-07-04 |
| Estimated end date | 2025-08-01 | 2025-08-01 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | We have identified a potential issue affecting the metal crimp cap within one batch. We are actively working on a resolution and available inventory will be expedited to support Canadian market. | We have identified a potential issue affecting the metal crimp cap within one batch. We are actively working on a resolution and available inventory will be expedited to support Canadian market. |
| Health Canada comments |